BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 20370918)

  • 1. The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer.
    Calaluce R; Gubin MM; Davis JW; Magee JD; Chen J; Kuwano Y; Gorospe M; Atasoy U
    BMC Cancer; 2010 Apr; 10():126. PubMed ID: 20370918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis.
    Gubin MM; Calaluce R; Davis JW; Magee JD; Strouse CS; Shaw DP; Ma L; Brown A; Hoffman T; Rold TL; Atasoy U
    Cell Cycle; 2010 Aug; 9(16):3337-46. PubMed ID: 20724828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA-binding protein HuR regulates GATA3 mRNA stability in human breast cancer cell lines.
    Licata LA; Hostetter CL; Crismale J; Sheth A; Keen JC
    Breast Cancer Res Treat; 2010 Jul; 122(1):55-63. PubMed ID: 19728080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells.
    Hostetter C; Licata LA; Witkiewicz A; Costantino CL; Yeo CJ; Brody JR; Keen JC
    Cancer Biol Ther; 2008 Sep; 7(9):1496-506. PubMed ID: 18769129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium.
    Fan J; Ishmael FT; Fang X; Myers A; Cheadle C; Huang SK; Atasoy U; Gorospe M; Stellato C
    J Immunol; 2011 Feb; 186(4):2482-94. PubMed ID: 21220697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global analysis of HuR-regulated gene expression in colon cancer systems of reducing complexity.
    López de Silanes I; Fan J; Galbán CJ; Spencer RG; Becker KG; Gorospe M
    Gene Expr; 2004; 12(1):49-59. PubMed ID: 15473260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of nitric oxide-stabilized mRNAs in human fibroblasts reveals HuR-dependent heme oxygenase 1 upregulation.
    Kuwano Y; Rabinovic A; Srikantan S; Gorospe M; Demple B
    Mol Cell Biol; 2009 May; 29(10):2622-35. PubMed ID: 19289500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer.
    Woo HH; Yi X; Lamb T; Menzl I; Baker T; Shapiro DJ; Chambers SK
    Mol Cell Biol; 2011 Jan; 31(1):215-25. PubMed ID: 20974809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR.
    Pryzbylkowski P; Obajimi O; Keen JC
    Breast Cancer Res Treat; 2008 Sep; 111(1):15-25. PubMed ID: 17891453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
    Guo X; Hartley RS
    Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HuR, a key post-transcriptional regulator, and its implication in progression of breast cancer.
    Yuan Z; Sanders AJ; Ye L; Jiang WG
    Histol Histopathol; 2010 Oct; 25(10):1331-40. PubMed ID: 20712017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold-inducible RNA-binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer.
    Guo X; Wu Y; Hartley RS
    Mol Carcinog; 2010 Feb; 49(2):130-40. PubMed ID: 19777567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells.
    Baldan F; Mio C; Allegri L; Conzatti K; Toffoletto B; Puppin C; Radovic S; Vascotto C; Russo D; Di Loreto C; Damante G
    Oncotarget; 2016 Sep; 7(39):63388-63407. PubMed ID: 27542231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells.
    Tan S; Ding K; Chong QY; Zhao J; Liu Y; Shao Y; Zhang Y; Yu Q; Xiong Z; Zhang W; Zhang M; Li G; Li X; Kong X; Ahmad A; Wu Z; Wu Q; Zhao X; Lobie PE; Zhu T
    J Biol Chem; 2017 Aug; 292(33):13551-13564. PubMed ID: 28637868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
    Tran H; Maurer F; Nagamine Y
    Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.
    Denkert C; Weichert W; Winzer KJ; Müller BM; Noske A; Niesporek S; Kristiansen G; Guski H; Dietel M; Hauptmann S
    Clin Cancer Res; 2004 Aug; 10(16):5580-6. PubMed ID: 15328200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of RNA binding protein HuR in ductal carcinoma in situ of the breast.
    Heinonen M; Hemmes A; Salmenkivi K; Abdelmohsen K; Vilén ST; Laakso M; Leidenius M; Salo T; Hautaniemi S; Gorospe M; Heikkilä P; Haglund C; Ristimäki A
    J Pathol; 2011 Aug; 224(4):529-39. PubMed ID: 21480233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a target RNA motif for RNA-binding protein HuR.
    López de Silanes I; Zhan M; Lal A; Yang X; Gorospe M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2987-92. PubMed ID: 14981256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells.
    Galbán S; Martindale JL; Mazan-Mamczarz K; López de Silanes I; Fan J; Wang W; Decker J; Gorospe M
    Mol Cell Biol; 2003 Oct; 23(20):7083-95. PubMed ID: 14517280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3' untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR.
    Suswam EA; Nabors LB; Huang Y; Yang X; King PH
    Int J Cancer; 2005 Mar; 113(6):911-9. PubMed ID: 15514971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.